BiotechTube
Nanion

Nanion

Munich, Germany· Est.
nanion.de
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Nanion Technologies is a privately held provider of advanced electrophysiology instrumentation and solutions, headquartered in Munich, Germany. The company's core business is developing and selling automated systems for studying ion channels and membrane transporters, which are critical targets in drug discovery. It serves a global customer base of academic researchers, contract research organizations (CROs), and pharmaceutical companies. Nanion's value proposition combines user-friendly, high-fidelity hardware and software with deep scientific support to improve the efficiency and accuracy of preclinical research.

Cardiac Safety (CiPA)CNSPainCancerImmune diseasesRespiratory diseasesRare diseasesMetabolic diseasesLysosomal diseases

Technology Platform

Portfolio of automated electrophysiology and cell analytics platforms including automated patch clamp systems (Port-a-Patch, Patchliner, SyncroPatch 384), membrane biophysics tools for transporters and nanopores (SURFE²R, Orbit), and impedance-based cell analyzers (CardioExcyte, FLEXcyte, AtlaZ).

Opportunities

Growth is driven by the expanding need for ion channel and transporter screening in drug discovery, particularly for cardiac safety (CiPA initiative) and complex diseases.
The unique SURFE²R technology positions Nanion to capture a leading share in the underserved transporter assay market.
Increased adoption of human iPSC-derived cells for disease modeling creates further demand for functional, physiological platforms.

Risk Factors

Faces intense competition from larger, well-established life science tool companies.
Revenue is susceptible to fluctuations in the R&D capital expenditure cycles of pharmaceutical and biotech clients.
The business is exposed to supply chain disruptions for critical electronic and consumable components.

Competitive Landscape

Nanion competes in the automated patch clamp market against major players like Molecular Devices (a Danaher company) and Sophion. Its key differentiation is a broader portfolio that includes unique transporter screening (SURFE²R) and cell analytics platforms, coupled with a strong emphasis on direct scientific customer support. In the membrane biophysics space, it competes with specialized firms and academic solutions.

More companies in Diagnostics & Precision Medicine →More companies in Germany →